chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient received a dose of the vaccine following temperature excursions on unknown dates; No adverse event; This spontaneous report as received from a medical assistant refers to a current 5-month-old patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant medications were not provided.   On an unknown date, the rotavirus vaccine, live, oral, pentavalent (ROTATEQ)  (lot # S013439 with expiration date 03-MAR-2021, lot # S013436 with expiration date 30-JAN-2021, and lot # S006050 with expiration date 12-DEC-2020) underwent a temperature excursion.   Temperature Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) Time frame 7 hours 30 minutes Previous temperature excursion? yes, Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) for 8 hours 30 minutes Was call because of a "data logger"? yes  On an unknown date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) at a dose of 2 ml (route not provided) as prophylaxis. No adverse events were reported.  This is one of several reports received from the same reporter  This spontaneous report as received from a other health professional refers to a patient of unknown age.    On an unknown date the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # S006050, 2 milliliter for prophylaxis.       On an unknown date the patient experienced product storage error and no adverse event.    The outcome of product storage error and no adverse event is unknown.   The reporter considered product storage error and no adverse event to be not assessed to Rotavirus Vaccine, Live, Oral, Pentavalent(ROTATEQ).     {Additional information has been requested. / Additional information is not expected.}; Sender's Comments:  US-009507513-2005USA003382: US-009507513-2005USA004545: US-009507513-2005USA004950: US-009507513-2005USA004951: US-009507513-2005USA004952: US-009507513-2005USA004953: US-009507513-2005USA004954: US-009507513-2005USA004955: US-009507513-2005USA004956: US-009507513-2005USA004957: US-009507513-2005USA004958: US-009507513-2005USA004959: US-009507513-2005USA004960: US-009507513-2005USA004961: US-009507513-2005USA004962: US-009507513-2005USA004963: US-009507513-2005USA004964: US-009507513-2005USA004965: US-009507513-2005USA004966: US-009507513-2005USA004967: US-009507513-2005USA004968: US-009507513-2005USA004969: US-009507513-2005USA004970: US-009507513-2005USA004971: US-009507513-2005USA004972: US-009507513-2005USA004973: US-009507513-2005USA004974: US-009507513-2005USA004975: US-009507513-2005USA004977: US-009507513-2005USA004978: US-009507513-2005USA004979: US-009507513-2005USA004980: US-009507513-2005USA004981: US-009507513-2005USA004982: US-009507513-2005USA004983: US-009507513-2005USA004984: US-009507513-2005USA004985: US-009507513-2005USA004986: US-009507513-2005USA004987: US-009507513-2005USA004988: US-009507513-2005USA004989: US-009507513-2005USA004990: US-009507513-2005USA004991: US-009507513-2005USA004992: US-009507513-2005USA004993:
Nausea and vomiting within 5 minutes of receiving the vaccine Chills about 7 hours after receiving vaccine Fatigue throughout the following day after receiving the vaccine
Blood clots (thrombus) found in my left thigh's vein, hence the swollen leg.  I am not 100% sure if it's related to the vaccine though.
Narrative:  Patient is a 72-y.o M whose past medical history includes hypertension, diabetes, hyperlipidemia, atrial fibrillation on routine anticoagulation who presents with complaints of fatigue/decreased energy over any number of days. Patient reports that on Monday, 10/18/2021 he had received his third COVID-19 booster as well as influenza vaccine. Patient then on the following day began experiencing fatigue and decreased energy in which she went to supermarket that day is having issues with ambulation. Patient had a ground-level fall at supermarket however he did not hit his head. Patient on throughout the week continue to have persistent fatigue/decreased energy in which he thought he had the flu would go away on its own. Due to worsening symptoms, patient presents to ED at onset of weekend. Admitted with Covid pneumonia and associated hypoxemia, among others. HOSPITAL COURSE: Slow improvement on oxygenation, cardiac status, and labile glycemic levels combine with sense of decreased energy in Covid positive pna patient. CONDITION AT DISCHARGE: stable in care of Self
07Sep90 pt vax w/ hepta B; exp severe chest tightness + dyspnea. next day devel rash on right forearm, exp n/, spinning sensation, malaise, flulike achiness, heart flutter. 4 days sx remitted and recovered.
full body erythematous rash on face, chest, shoulders, back of elbows, front of knees, and top of feet.
This case was reported by a consumer via call center representative and described the occurrence of shingles in a 68-year-old male patient who received Herpes zoster SHINGRIX for prophylaxis. On 9th March 2021, the patient received the 1st dose of SHINGRIX. On 16th March 2021, 7 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was not recovered/not resolved. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: The patient had reported the case for himself. The patient received vaccine in his left arm at his doctor's office. The patient did not know lot or expiration date of SHINGRIX vaccine. The patient reported with concern that he contracted shingles after receiving SHINGRIX vaccine. The patient stated that he developed a full case of shingles and his symptoms had not resolve as of the reporting time. The patient gave consent to follow up with his health care professional. The reporter did not wish to have SHINGRIX emailed to him, nor did he wish to have the company telephone number to give to his health care professional. The reporter was transferred to patient assistance for questions regarding SHINGRIX financial questions. The consent to follow-up was granted.
Pfizer-BioNTech COVID-19 Vaccine EUA  around 2:30 am began having chills, and muscular aches both of which continued for approximately 18 hours. around 7:30  am began also having headaches which persisted for about 12 hours. Also had fatigue, possible due to not sleeping well due to sx. Around 10:00 am began having difficulty concentrating, headaches, muscle aches and chills intensified. Around 11am confirmed fever of 100 d F, took Tylenol which lessened chills. General malaise continued through evening, 8pm, took another Tylenol, by 9 pm began having series of intense and persistent (nonstop) heart related symptoms (chest pounding, tachycardia, shortness of breath,) which continued for several hours. (exact time unknown, I am guessing it lessened around 2am or so.) Following am, all symptoms gone. (might have continued to have some intermittent heart stuff as that has been ongoing every day, but non-stop intense cardiac feelings were not continuing by morning.
Patient was non- symptomatic following 24 hrs post vaccine but then began to have swelling, large redness, tenderness and itchiness. Patient stated that the site was also warm to touch. Patient came back into Immunization clinic to report that the redness, swelling and tenderness has now traveled down her arm into her right Bicep. Patient denies and additional symptoms. Patient did state that around the same time she noticed the symptoms she was also experiencing symptoms of nausea, fatigue and diarrhea. Patient is currently not experiencing same symptoms aside the redness, swelling and tenderness.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. Medical history and drug reactions/allergies were not reported. On an unknown date, the patient ws vaccinated with M-M-R II (lot, dose and route not reported). Concomitant medication was not reported. On 22-JUL-2014, the patient called into the pharmacy stating she had "low titers" after receiving M-M-R II. The outcome of the event was unknown. Additional information is not expected.
4/20/05 Received vaccinations Dtap, IPV, MMR, 12 hr later fever, swollen left arm, swelling grapefruit sized in deltoid, swollen 1/2 way to elbow, red, fever 101-102. ER visit prescribed Keflex 250mg TID x 10 day and Motrin for pain. Improved after 3 days. 5/2/05 recovered.
persistent generalized uticaria starting 24 hours following  vaccine. Requiring steroids and antihistamines to suppress or comes back
Fever, nausea, vomiting, diarrhea, headache, generalized joint and muscle pain. Treated with TYLENOL and PEPTO BISMOL. Fever, nausea, vomiting, and generalized pain absent 36 hours after initial presentation. Diarrhea and headache reduced, but still present after 50+  hours.
Injection site mass, pain, warm sensation - Information has been received from a registered nurse concerning a 36 year old African American female who on 08-Jan 2001 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation booster dose 633817/0172k subcutaneously in the left arm.  The registered nurse reported that the patient returned on 26 Jan 2001 and told the nurse that her arm was warm and had a small bump in her arm where the injection was given.  In follow up the registered nurse reported that the patient's arm is warm tender to touch, small egg size lump present at site where given.  The nurse reported that one week later it is much improved, mass decreased in size and patient denies complaints.  The registered nurse reported that the patient recovered.  No further information is available.
It felt like the worst cold I ever had. My sinuses were totally congested. I had a sore throat, headache, fever, and a cough. I feel better now but I'm fatigue with a little bit of congestion.
little sore arm; A spontaneous report was received from a 66-year-old female consumer who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced just a little sore arm.    The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included acetylsalicylic acid, rosuvastatin, metoprolol, vitamin D, ascorbic acid, and vitamin B12.   On 04 Jan 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection.   After receiving the vaccine, the patient experienced her arm being just a little sore. No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, just a little sore arm, was considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Headache and nausea on day of vaccine. 10 days after vaccine, got period although I am in menopause. Tinnitus and hearing problems noticeably increased (I would say doubled). Ringing in ears is twice as loud as before.
Patient received Moderna Vaccine on 04/13/2021 and received Janssen Vaccine today 09/08/2021.
acute sharp pain in lower rib cage , HR elevated to 150's while walking then went back down to 110 after 5-10 minutes , HR is now 92 ... and  coolness in L arm for 10-15min  He states he used marijuana an hour prior to the onset of these sx. Called his mother and was advised to call the COVID hotline and report  RN recommended that he self monitor and to discontinue the marijuana for a few days to make sure that didnt exacerbate or cause the reactions. He was agreeable
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unspecified age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2014, patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot# and expiration date were not provided), as prescribed and/or administered by a healthcare provider, for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to patient's zoster vaccine live (ZOSTAVAX) inoculation, patient was treated by Advanced Practice Registered Nurse (APRN), for shingles. As a direct and proximate result of patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.
Migraine headache preceded by visual aura. Took Tylenol at onset of symptoms.
Started to have joint/muscle/bone pain - felt like a RA flair. The worst day was Saturday and slowly subsided. Has RA.
This spontaneous report was received from a back office lead and refers to a 58 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 25-MAR-2016, the patient was vaccinated with the improperly stored dose of RECOMBIVAX HB (1 ml, intramuscularly in left deltoid, lot # reported as 042846 (verified to be non-valid), expiration date 15-SEP-2017). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information is not expected as all the correspondence was returned by the post office.
Client received immunization approximately 0830 am, of DTaP, Hib and Hep A, Pt has had no previous reaction to immunizations. Mother reports at 10:30 child had hives described as flat red rash on face, arms and chest. Treated with 1 tsp. of p.o. Benadryl, rash resolved, no other symptoms.
Tingling in legs; Tingling in feet; Numbness in legs; Numbness in feet; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on an unspecified date in Mar2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On an unspecified date in Mar2021, the patient experienced tingling and numbness in legs and feet nine days out. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events tingling and numbness in legs and feet was not resolved at the time of the report.  No follow-up attempts are possible; information about lot number cannot be obtained.
My last shot was 02/09/21  7 weeks after I developed Bells Palsey.  I had never had this before.
all of them and the booster; Came positive from Covid/ Positive from Covid; Came positive from Covid/ Positive from Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (004756).  A 86 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported:IMMUNISATION (medically significant),outcome "unknown", described as "all of them and the booster  COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "Came positive from Covid/ Positive from Covid"; The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive.  Additional information: The reporter stated that "his grandma (grandmother), 86 years old, came positive from Covid, and wants to know or find out about the Paxlovid, if it was being distributed or not, so his grandmother was positive from Covid. The reporter stated that they just enquired for Paxlovid of the Pfizer, but since there was already an adverse event so, and need to report it. No, this was for the Paxlovid." The reporter stated, "I want to know how the Paxlovid was available, if it was available, said, if it was available through has to be prescribe or over the counter or not", and the reporter was informed about this information. When asked if the patient received any of the Covid19 Vaccine, then the reporter stated, "Yes, all of them and the booster but was not provided with any answer to his question, already waited 20 minutes just to get to talk and all that happening was to collect more information from reporter and not provided to any of the asked information." When asked for permission for further probing, the reporter stated, "Absolutely not, No."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
UTI; This is a spontaneous report from a contactable consumer. This female consumer reported for herself that on an unspecified age she received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route administration on 26Jan2021 at single dose for COVID-19 immunization. The patient medical history included ongoing urinary tract infection, she said the UTI does not have anything to do with the vaccine.  She was having symptoms before she got it. The patient concomitant medications were not reported.  The patient experienced urinary tract infection on an unspecified date. Caller received the covid vaccine on Tuesday where she had already started to feel slight symptoms of the UTI. Yesterday she called her doctor, this morning she took the urine tests and was prescribed Bactrim. She had taken 1 pill already when she realized. She called her doctor office where she was told it should be fine. Caller would like to know if she may take Bactrim, which was prescribed for a urinary tract infection, after taking the covid vaccine. Caller would like to know if it is true that one should not take alcohol up to 3 days prior to the covid vaccine. Upon Follow-up (29Jan2021): It was reported that received call from consumer regarding the Pfizer COVID vaccine patient had it on 26Jan2021 and came down with a UTI and her doctor gave her Bactrim, antibiotic, for the UTI. patient would like to know if she can take it or will it affect the immunity of the vaccine.  She said the UTI does not have anything to do with the vaccine. She was having symptoms before she got it. Patient received the treatment with Bactrim, antibiotic, for the UTI. The outcome of event was unknown.  Follow-up (29Jan2021): This is a spontaneous report from a contactable consumer. The new information included: clinical information added, Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Information has been received from a physician concerning a female who was vaccinated intramuscularly with a first dose of Gardasil (lot # "0014V"). Almost immediately after the vaccination, the patient experienced pain at the injection site, cold and numbness is her left arm and was unable to make a fist with her left hand. Seven minutes later the patient experienced dizziness. The physician reported that the patient's blood pressure lower then normal at that time. Fourteen minutes later the patient developed a fever of 101 degrees. The patient was treated with ibuprofen 600 mg. Twenty-five minutes later patient's fever 99.1 degrees and her other vital signs were stable. Subsequently, the patient recovered and was sent home. Additional information has been requested.
Lathargic, non responsive, followed by behavior changes!   help! 12/14/09 Medical records received for date 10/30/09. OV for c/o anxiety and states shutting down at times, pt referred to therapist. OV 12/12/09 DX: URI, LOM. Chief c/o left ear pain. VAERS report received. Parents stated pt became sad immed following vax. Noted marital issues at home, pt. upset about this. Adverse event occurred 10/29/09.
Patient complained of chest pain, admitted to emergency room and being treated with tests. doctor thinks vaccine may have caused the inflammation of the heart lining.
breakout of hives throughout body, Welts; itching; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (breakout of hives throughout body, Welts) and PRURITUS (itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (breakout of hives throughout body, Welts) and PRURITUS (itching). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, URTICARIA (breakout of hives throughout body, Welts) and PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.